Filtered By:
Therapy: Radiation Therapy
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 20097 results found since Jan 2013.
Effects of a multidisciplinary quality of life intervention on sleep quality in patients with advanced cancer receiving radiation therapy - CORRIGENDUM.
PMID: 31640838 [PubMed - as supplied by publisher]
Source: Palliative and Supportive Care - October 22, 2019 Category: Palliative Care Authors: Gentry MT, Atherton PJ, Lapid M, Rosen PS, Kung S, Richardson J, Niazi SK, Bobo WV, Clark MM, Rummans TA Tags: Palliat Support Care Source Type: research
A population-based assessment of proton beam therapy utilization in California.
CONCLUSIONS: Significant differences exist in PBT use by demographics and health insurance type. The identified racial and socioeconomic disparities merit further investigation. More granular studies on both use patterns and effectiveness of PBT for specific cancers are needed to draw stronger conclusions about its cost-benefit ratio.
PMID: 32059097 [PubMed - in process]
Source: The American Journal of Managed Care - January 31, 2020 Category: Health Management Authors: Parikh-Patel A, Morris CR, Maguire FB, Daly ME, Kizer KW Tags: Am J Manag Care Source Type: research
Holistic care approach for the effective management of severe radiation dermatitis using neem (Azadirachta indica) and honey after head & #8211;and-neck radiotherapy
Sabita Sahu, Yashawant Ramawat, Nitesh Kumawat, Ranjit Kumar Sahu, Vijay Kumar, Machhendra NathIndian Journal of Palliative Care 2020 26(4):540-543
Head and neck cancer is the eighth common type among all cancer types around the world. Its treatment comprises surgery, radiation therapy, chemotherapy and /or a combination of restoration therapy and social support Conventional fraction size ranges from 1.8 to 3 Grays (Gy) per fraction over 4–6 weeks. The accumulative dose of radiation for the primary treatment of head and neck cancer treatment is 60 to 70 Gy, depending on the irradiation of the tumor. Ionizing ...
Source: Indian Journal of Palliative Care - November 19, 2020 Category: Palliative Care Authors: Sabita Sahu Yashawant Ramawat Nitesh Kumawat Ranjit Kumar Sahu Vijay Kumar Machhendra Nath Source Type: research
Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?
Image-guided high-intensity focused ultrasound (HIFU) has been increasingly used in medicine over the past few decades, and several systems for such have become commercially available. HIFU has passed regulatory approval around the world for the ablation of various solid tumors, the treatment of neurologic diseases, and the palliative management of bone metastases. The mechanical and thermal effects of focused ultrasound provide a possibility for histotripsy, supportive radiation therapy, and targeted drug delivery. The integration of imaging modalities into HIFU systems allows for precise temperature monitoring and accura...
Source: Journal of Nuclear Medicine - September 2, 2021 Category: Nuclear Medicine Authors: Zhang, X., Landgraf, L., Bailis, N., Unger, M., Jochimsen, T. H., Melzer, A. Tags: State of the Art Source Type: research
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
In this report, we present the case of a 3-year-old girl with glioblastoma who continues to experience an exceptional and durable response (>2 years) to the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib. Our patient presented with persistent and progressive seizure activity that upon workup was the result of a large heterogeneously enhancing, mixed cystic and solid mass in the left frontal-parietal-temporal region. Histopathologic analysis of resected tumor tissue confirmed the diagnosis of glioblastoma, and comprehensive genomic profiling demonstrated absence of any BRAF or H3F3A mutations. Genomic profiling...
Source: The Oncologist - October 15, 2019 Category: Cancer & Oncology Authors: Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram DE, Severson E, Hemmerich A, Edgerly C, Duncan D, Britt N, Huang RSP, Elvin J, Miller V, Ross JS, Gay L, McCorkle J, Rankin A, Erlich RL, Chudnovsky Y, Ramkissoon SH Tags: Oncologist Source Type: research
Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy.
CONCLUSIONS: Utilizing the concept of INRT results in a reduction of radiation dose to critical organ structures in pediatric patients with Hodgkin lymphoma when compared to the more traditional method of IFRT.
PMID: 25082095 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 28, 2014 Category: Radiology Authors: Mulvihill DJ, McMichael K, Goyal S, Drachtman R, Weiss A, Khan AJ Tags: Radiother Oncol Source Type: research
Top Artificial Intelligence Companies in Healthcare to Keep an Eye On
The field of medical AI is buzzing. More and more companies set the purpose to disrupt healthcare with the help of artificial intelligence. Here, I collected the biggest names currently on the market ranging from start-ups to tech giants to keep an eye on in the future.
Artificial Intelligence has to and will redesign healthcare
No one doubts that artificial intelligence has unimaginable potential. Within the next couple of years, it will revolutionize every area of our life, including medicine. Although many have their fears and doubts about AI taking over the world, Stephen Hawking even said that the development of full ...
Source: The Medical Futurist - January 31, 2017 Category: Information Technology Authors: nora Tags: Artificial Intelligence in Medicine Healthcare Design AI big data digital health drug development GC1 genetics healthcare companies Innovation medical imaging Personalized medicine pharma Source Type: blogs
PROP ’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences
ConclusionDespite being turned back from an effort to bluntly reduce opioid prescribing by the FDA in 2013 based on a lack of scientific evidence for its position (17,18), PROP has had a disproportionate effect on opioid policy in the Untied States for almost a decade. PROP found a willing federal regulatory partner in the CDC, and while PROP may not have “secretly written” the 2016 CDC Pain Guidelines (75), they certainly enjoyed disproportionate representation on CDC’s review panels and Core Expert Group (23-25) in a process that lacked transparency (22, 23, 26, 27). When the CDC admitted that its Pain Guideline ha...
Source: Pallimed: A Hospice and Palliative Medicine Blog - May 3, 2021 Category: Palliative Care Tags: CDC health policy kollas opioids pain prop Source Type: blogs
PROP s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences
ConclusionDespite being turned back from an effort to bluntly reduce opioid prescribing by the FDA in 2013 based on a lack of scientific evidence for its position (17,18), PROP has had a disproportionate effect on opioid policy in the Untied States for almost a decade. PROP found a willing federal regulatory partner in the CDC, and while PROP may not have secretly written the 2016 CDC Pain Guidelines (75), they certainly enjoyed disproportionate representation on CDCs review panels and Core Expert Group (23-25) in a process that lacked transparency (22, 23, 26, 27). When the CDC admitted that its Pain Guideline had been...
Source: Pallimed: A Hospice and Palliative Medicine Blog - May 3, 2021 Category: Palliative Care Tags: CDC health policy kollas opioids pain prop Source Type: blogs
Nonurological malignancies in children
Conclusions: Treatment results vary from center to center depending on access to resources and following different management protocols. Results have improved for these tumors with the advent of newer chemotherapeutic agents, novel delivery methods of radiation therapy (RT), and improvement in surgical technique. Due to the limited number of patients presenting with these tumors, national and international collaboration of data is critical for all and beneficial to individual treatment centers. This has resulted in better results in the past and will definitely result in still better results in the future.
Source: Journal of Indian Association of Pediatric Surgeons - January 28, 2014 Category: Surgery Authors: Lalit Parida Source Type: research
HIV Did Not Stop Me From Having a Biological Child
On Monday, April 15, 2013, at 8:00 a.m., my life changed forever. My wife, Kasiah, and I welcomed our first child, a healthy girl named Finley Elizabeth Banks, into this world. She was perfect. But the journey to have a healthy, HIV-free biological child began many years before Finley’s birth.
MoreFederal Appeals Court Strikes Down Utah's Gay Marriage Ban NBC NewsJessica N. Turner: Moms, Put on That Swimsuit Huffington PostShould the Cops Get to Look at Your Cellphone? NBC NewsParty's Over? GOP's Insurgents Take More Punches NBC NewsUruguay eliminates Italy; Did Suarez bite again? Sports IllustratedIn 1981, when I wa...
Source: TIME.com: Top Science and Health Stories - June 25, 2014 Category: Consumer Health News Authors: clairehoworth Tags: Uncategorized AIDS research Family & Parenting Fatherhood HIV medicine Science Source Type: news
Top Artificial Intelligence Companies in Healthcare to Keep an Eye On
The field of medical AI is buzzing. More and more companies set the purpose to disrupt healthcare with the help of artificial intelligence. Given how fast these companies come and go, it can prove to be hard to stay up-to-date with the most promising ones. Here, I collected the biggest names currently on the market ranging from start-ups to tech giants to keep an eye on in the future.
To further help you keep up with what A.I. brings to medicine, The Medical Futurist team made an easy-to-digest e-book about just that. I highly encourage you to read it and would love to hear about your thoughts!
Artificial Intelligence has ...
Source: The Medical Futurist - January 21, 2020 Category: Information Technology Authors: berci.mesko Tags: Artificial Intelligence Healthcare Design AI digital health genetics Innovation Personalized medicine pharma GC1 big data drug development healthcare companies medical imaging Source Type: blogs
Clinical considerations for using PET/CT in Radiation Therapy
Conclusions There are three major categories to consider when starting collaboration with the RO department including equipment, scheduling, and communication. With these areas in place there are many new services that can be offered. All of these services can help build strong clinical collaborations and strengthen the PET/CT business while also improving the quality of patient care.
Source: Journal of Nuclear Medicine - May 23, 2016 Category: Nuclear Medicine Authors: Acuff, S., Jackson, A., Osborne, D. Tags: MTA I: Technologist Posters Source Type: research
Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy
Involved field radiotherapy (IFRT) after cytotoxic chemotherapy has become the standard of care in treating pediatric patients with Hodgkin lymphoma. However, recent interest in shrinking the treatment volume to involved node radiotherapy (INRT) may allow lower doses to critical organ structures. We dosimetrically compared IFRT and INRT treatment approaches.
Source: Radiotherapy and Oncology - July 28, 2014 Category: Radiology Authors: David J. Mulvihill, Kevin McMichael, Sharad Goyal, Richard Drachtman, Aaron Weiss, Atif J. Khan Source Type: research
